Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer ( s is:www.molecularinsight.com. Forwa...)

HOME >> MEDICINE >> TECHNOLOGY

Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer

s is: www.molecularinsight.com.

Forward-Looking Statements

Statements in this release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, statements about the development of Azedra(TM), Onalta (TM), Zemiva(TM) and our other product candidates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results of Molecular Insight to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for product candidates; competition from other pharmaceutical or biotechnology companies; and the additional risks discussed in filings with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement, and Molecular Insight undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.

Contact

Molecular Insight Pharmaceuticals, Inc.
Priscilla Harlan, 617-492-5554
Vice President, Corporate Communications
& Investor Relations

Page: 1 2 3 4
Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
3. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
4. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
5. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference

Post Your Comments:

(Date:11/6/2009)...IEGO, Nov. 6 Trius Therapeutics, I...on statement on Form S-1 with the U.S. Securities ...ed initial public offering of shares of its common...in the offering will be offered by the Company. ,...s sole book-running manager, Piper Jaffray & C...

(Date:11/6/2009)...IT, Nov. 6 Caraco Pharma... launched ketorolac tromethamine ophthalmic soluti...od and Drug Administration (FDA) for Sun Pharma,s ...c Acular® ophthalmic solution on the first da...torolac is therapeutically equivalent to Acular...

(Date:11/6/2009)...IEGO, Nov. 6 NuVasive, I...used on developing products for minimally disrupti...day the appointment of Michael J. Lambert as Execu...ffective November 9, 2009. The Company also annou...es. ,, "Michael will be an excellent complement...

Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2 NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2 NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3 NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4 NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5 Strep B Seems to Trick Immune System 51448 1 Bathtub Accidents Injure 43 000 U S Kids Each Year 51446 1 Bathtub Accidents Injure 43 000 U S Kids Each Year 51446 2 National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio August 31 September 1 51444 1 National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio August 31 September 1 51444 2

[0] Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering [0] Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution [0] NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates

...ew procedure could offer a safer, more convenient ... For orthopaedic researcher Joyce Keyak, Ph.D., f...as well as a professional mission. Her cousin died...ll remembers the incredible pain her cousin experi...tudy released by Dr. Keyak and her colleagues at t...

...ASHINGTON, Feb. 20 The Association of Clinical Re...clinical outsourcing industry to regulators, bioph... in the U.S. and worldwide, issued the following c...ications of the Globalization of Clinical Research... New England Journal of Medicine : , , The artic...

Other Medicine Technology:Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 2 Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 3 ACRO Comments on NEJM Article on Globalization of Clinical Research 2 ACRO Comments on NEJM Article on Globalization of Clinical Research 3

Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads ACRO Comments on NEJM Article on Globalization of Clinical Research

(Date:11/8/2009)...e/ -- Pharmaceutical Research and Manufacturers of... released the following statement regarding the Ho...inted, but not surprised by today,s vote -- an une...s as well as nearly half of the members of the U.S...ill. ,, "While well intentioned, the bill -- as...

(Date:11/8/2009)...re Reform Bill ,, Critical legislation would ...icans ,, BALTIMORE, Nov. 7 /PRNewswire-USNewsw... of Representatives passed critical health care re...r seniors and end discrimination by insurance comp...ordable health coverage. ,, The Affordable Heal...

(Date:11/7/2009)...-- The American Medical Association (AMA) proudly ...mily Violence Prevention Fund, with the Citation f...policy-making meeting. The Citation for Distingui... Delegates bestows on a non-physician. ,, (Lo...9/AMALOGO ) ,, "Ms. James has worked selfless...

(Date:11/7/2009)...onsibility to vigorously oppose abortion in health...NGTON, Nov. 7 Americ...following statement on the news that Cardinal Just...rdable Health Care for America Act (H.R. 3962), pr...abortion is voted upon. ,, "Our Catholic bisho...

(Date:11/7/2009)...bel, expert says , , SATURDAY, Nov. 7 (Hea...dly if their parents expect them to, a new U.S. st...ply being realistic might actually contribute to a...ychology professor at Wake Forest University and a...elease. "Negative expectations on the part of both...

Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2 Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3 Health News:AARP Maryland Key Vote News Alert 2 Health News:AARP Maryland Key Vote News Alert 3 Health News:AMA Honors Family Violence Prevention Expert 2 Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2 Health News:Bad-Behaving Teens May Be Living Up to Expectations 2

[0] PhRMA Statement on House Passage of Health Care Reform Bill [0] AARP Maryland Key Vote News Alert [0] AMA Honors Family Violence Prevention Expert [0] Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life [0] Bad-Behaving Teens May Be Living Up to Expectations

... China, May 23 /Xinhua-Prnewswire-FirstCall/ -- Ch...I), a manufacturer, marketer and,distributor of ph... China,today announced that its common shares have...s contingent upon China Sky One,Medical being in c...

... May 21 "American Right To Life is,offering attor... group,s,president Brian Rohrbough, "if he can nam...rt who has ever acknowledged that the unborn child... work toward federal personhood legislation, they ...

..., May 22 The 39th gathering of the Texas Annual,C...ure a 60-member West,African choir to help celebra...d the groundbreaking partnership between Methodist...igning on May 28 at 10:45 a.m., will affirm,the co...

...TOR,S PICK: Anti-HIV drugs reduce the cause of som...eutic use for anti-HIV drugs known as protease inh...s from Harvard Medical School, Boston, and Inserm ...e death (by a process known as apoptosis) of nerve...

...4 mg Lozenge helps reverse symptoms associated wit...ntrating, attention deficit, memory ...RGH, May 22 In light of today,s,announcement by t...and air-traffic controllers, it,s important to not...

...r-based test delivery provides greater convenience...tification, WASHINGTON, May 22 The Pharmacy Tech...that over 300,000 pharmacy,technicians have offici...or transfer process since the program,s inception,...

China Sky One Medical, Inc. Approved for Listing on the American Stock Exchange $10,000 Offer to National RTL From American RTL to Name 'One' Pro-Life Justice Local Methodists Host West African Choir, South African Leader at Historic Conference JCI table of contents: May 22, 2008 Nicotine Replacement Therapy Is Safe, Effective and Can Help Reverse Mental Acuity Deficits in Smokers Who Are Quitting, Including Commercial and Private Pilots Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT)

MEDPOR Superior Lateral Orbital Rim

MEDPOR Inferior Orbital Rims

MEDPOR Orbital Rim Onlay Implants

Akahoshi Prechop (12 o'clock approach)

Medicine Products:

MEDPOR Superior Lateral Orbital Rim MEDPOR Inferior Orbital Rims MEDPOR Orbital Rim Onlay Implants Akahoshi Prechop (12 o'clock approach)

( s is:www.molecularinsight.com. Forwa...)Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer,Health